Abstract:Pharmacokinetic/pharmacodynamic (PK/PD) modelling is the initial step in the semi-mechanistic approach for optimizing dosage regimens for systemically acting antimicrobial drugs (AMDs). Numerical values of PK/PD indices are used to predict dose and dosing interval on a rational basis followed by confirmation in clinical trials. The value of PK/PD indices lies in their universal applicability amongst animal species. Two PK/PD indices are routinely used in veterinary medicine, the ratio of the area under the curve of the free drug plasma concentration to the minimum inhibitory concentration (MIC) (fAUC/MIC) and the time that free plasma concentration exceeds the MIC over the dosing interval (fT > MIC). The basic concepts of PK/PD modelling of AMDs were established some 20 years ago. Earlier studies have been reviewed previously and are not reconsidered in this review. This review describes and provides a critical appraisal of more recent, advanced PK/PD approaches, with particular reference to their application in veterinary medicine. Also discussed are some hypotheses and new areas for future developments. First, a brief overview of PK/PD principles is presented as the basis for then reviewing more advanced mechanistic considerations on the precise nature of selected indices. Then, several new approaches to selecting PK/PD indices and establishing their numerical values are reviewed, including (a) the modelling of time-kill curves and (b) the use of population PK investigations. PK/PD indices can be used for dose determination, and they are required to establish clinical breakpoints for antimicrobial susceptibility testing. A particular consideration is given to the precise nature of MIC, because it is pivotal in establishing PK/PD indices, explaining that it is not a "pharmacodynamic parameter" in the usual sense of this term.

Application of PK/PD Modeling in Veterinary Field: Dose Optimization and Drug Resistance Prediction

Pharmacokinetics/Pharmacodynamics models of veterinary antimicrobial agents

Application of physiologically based pharmacokinetic models to promote the development of veterinary drugs with high efficacy and safety

Progress on pharmacokinetics/pharmacodynamics of antimicrobial agents

Review on the Integration and Model of Pharmacokinetic and Pharmacodynamic Data of Antibiotics Used in Veterinary Medicine

The pharmacokinetic/pharmacodynamic paradigm for antimicrobial drugs in veterinary medicine: Recent advances and critical appraisal.

Pharmacokinetic/pharmacodynamic integration in drug development and dosage-regimen optimization for veterinary medicine

Pharmacokinetic-Pharmacodynamic Modeling of Antibacterial Drugs

Research Progress on the Impact of Veterinary Drugs Residues on Bacteria Resistance in Environment

Animal pharmacokinetics/pharmacodynamics (PK/PD) infection models for clinical development of antibacterial drugs: lessons from selected cases.

Application of Semi-Mechanistic Pharmacokinetic and Pharmacodynamic Model in Antimicrobial Resistance

The Role of PK/PD Analysis in the Development and Evaluation of Antimicrobials

Review on Population Pharmacokinetics/Pharmacodynamics of Antibiotics Used in Veterinary Drug

The Application of Population Pharmacokinetic Model to Individualized Antibiotic Therapy

Pharmacokinetic-pharmacodynamic Modeling of Cyadox Against Escherichia Coli in Swine

Research Progress of the Veterinary Population Pharmacokinetic

Corrigendum to “application of PK/PD Modeling in Veterinary Field: Dose Optimization and Drug Resistance Prediction”

Pharmacodynamic Parameters of Pharmacokinetic/Pharmacodynamic (PK/PD) Integration Models

Application of PK/PD Parameters in Selection of Antibiotic Regimes for Patients with Multi-Drug Resistant Bacterial Infection

Optimization of Antimicrobial Treatment to Minimize Resistance Selection

Interest in antibiotic pharmacokinetic modelling in the context of optimising dosing and reducing resistance: bibliometric analysis